Laura Evgin

2.3k total citations · 1 hit paper
28 papers, 987 citations indexed

About

Laura Evgin is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Laura Evgin has authored 28 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Genetics and 12 papers in Immunology. Recurrent topics in Laura Evgin's work include Virus-based gene therapy research (18 papers), CAR-T cell therapy research (18 papers) and Immunotherapy and Immune Responses (9 papers). Laura Evgin is often cited by papers focused on Virus-based gene therapy research (18 papers), CAR-T cell therapy research (18 papers) and Immunotherapy and Immune Responses (9 papers). Laura Evgin collaborates with scholars based in United States, Canada and United Kingdom. Laura Evgin's co-authors include Richard G. Vile, John C. Bell, Theresa Falls, David H. Kirn, Kelley A. Parato, Caroline J. Breitbach, Jill Thompson, Jason M. Tonne, Kevin G. Shim and Matthew Schuelke and has published in prestigious journals such as Nature Communications, Blood and Brain.

In The Last Decade

Laura Evgin

27 papers receiving 970 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct in vivo CAR T cell engineering

2024 52 citations Robert A. Holt, Pieter R. Cullis et al. Trends in Pharmacological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Evgin United States	16	646	639	378	261	121	28	987
Johanna K. Kaufmann Germany	13	497 0.8×	551 0.9×	451 1.2×	325 1.2×	90 0.7×	26	1.0k
Juan J. Rojas Spain	17	731 1.1×	575 0.9×	455 1.2×	170 0.7×	196 1.6×	23	967
Roshni Ravindranathan United States	12	727 1.1×	805 1.3×	337 0.9×	432 1.7×	157 1.3×	17	1.1k
Dominic G. Roy Canada	18	708 1.1×	644 1.0×	466 1.2×	391 1.5×	164 1.4×	31	1.2k
Mena Mansour United States	11	565 0.9×	684 1.1×	354 0.9×	349 1.3×	110 0.9×	23	1.2k
Jayson Hardcastle United States	10	572 0.9×	475 0.7×	353 0.9×	237 0.9×	104 0.9×	11	853
Meijun Zheng China	12	314 0.5×	501 0.8×	231 0.6×	251 1.0×	78 0.6×	26	806
Siri Tähtinen Finland	20	837 1.3×	1.0k 1.6×	670 1.8×	564 2.2×	226 1.9×	32	1.6k
Minna Oksanen Finland	17	726 1.1×	666 1.0×	367 1.0×	210 0.8×	187 1.5×	24	884
João M. Santos Finland	18	691 1.1×	823 1.3×	336 0.9×	366 1.4×	212 1.8×	39	1.1k

Countries citing papers authored by Laura Evgin

Since Specialization

Citations

This map shows the geographic impact of Laura Evgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Evgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Evgin more than expected).

Fields of papers citing papers by Laura Evgin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Evgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Evgin. The network helps show where Laura Evgin may publish in the future.

Co-authorship network of co-authors of Laura Evgin

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Evgin. A scholar is included among the top collaborators of Laura Evgin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Evgin. Laura Evgin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tonne, Jason M., Jill Thompson, Alex Chen, et al.. (2025). T cell exhaustion in poorly immunogenic HCC is partially rescued by checkpoint blockade but suppressed by oncolytic virotherapy. Molecular Therapy. 33(12). 6178–6194.

Bernard, Gordon R. & Laura Evgin. (2025). Non-signaling but all important: how the linker, hinge, and transmembrane domains in the CAR hold it all together. Frontiers in Immunology. 16. 1664403–1664403. 2 indexed citations

Holt, Robert A., et al.. (2024). Direct in vivo CAR T cell engineering. Trends in Pharmacological Sciences. 45(5). 406–418. 52 indexed citations breakdown →

Webb, Mason, Jacob P. van Vloten, Laura Evgin, et al.. (2024). Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nature Communications. 15(1). 5442–5442. 37 indexed citations

Meermeier, Erin W., Silvia Selleri, Mehdi Arbabi Ghahroudi, et al.. (2023). Lymphodepletion Enables Successful BCMA CAR-T Cell Engraftment and Tumour Control in the Syngeneic Vk*MYC Model of Aggressive Myeloma. Blood. 142(Supplement 1). 3445–3445. 1 indexed citations

Evgin, Laura, et al.. (2023). Expansion and Retroviral Transduction of Primary Murine T Cells for CAR T-Cell Therapy. Methods in molecular biology. 2748. 41–53. 1 indexed citations

Driscoll, Christopher B., Matthew Schuelke, Timothy Kottke, et al.. (2020). APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nature Communications. 11(1). 790–790. 49 indexed citations

Huff, Amanda L., Laura Evgin, Jill Thompson, et al.. (2020). Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses. Molecular Therapy. 28(12). 2540–2552. 5 indexed citations

Evgin, Laura, Amanda L. Huff, Phonphimon Wongthida, et al.. (2020). Oncolytic virus-derived type I interferon restricts CAR T cell therapy. Nature Communications. 11(1). 3187–3187. 92 indexed citations

10.

Evgin, Laura, Amanda L. Huff, Timothy Kottke, et al.. (2019). Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment. Cancer Immunology Research. 7(5). 828–840. 13 indexed citations

11.

Nace, Rebecca A., et al.. (2019). Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9. Molecular Therapy — Oncolytics. 16. 63–74. 34 indexed citations

12.

Schuelke, Matthew, Phonphimon Wongthida, Jill Thompson, et al.. (2019). Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity. Journal for ImmunoTherapy of Cancer. 7(1). 188–188. 10 indexed citations

13.

Uusi-Kerttula, Hanni, James A. Davies, Jill Thompson, et al.. (2018). Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies. Clinical Cancer Research. 24(17). 4215–4224. 38 indexed citations

14.

Shim, Kevin G., Shane Zaidi, Jill Thompson, et al.. (2017). Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy. Molecular Therapy. 25(4). 962–975. 19 indexed citations

15.

Kottke, Tim, Kevin G. Shim, Vanesa Alonso-Camino, et al.. (2016). Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular Therapy — Oncolytics. 3. 16030–16030. 3 indexed citations

16.

Ilett, Elizabeth J., Tim Kottke, Jill Thompson, et al.. (2016). Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy. Gene Therapy. 24(1). 21–30. 59 indexed citations

17.

Muharemagic, Darija, Anna S. Zamay, Shahrokh M. Ghobadloo, et al.. (2014). Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies. Molecular Therapy — Nucleic Acids. 3. e167–e167. 19 indexed citations

18.

Parato, Kelley A., Caroline J. Breitbach, Fabrice Le Bœuf, et al.. (2011). The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers. Molecular Therapy. 20(4). 749–758. 224 indexed citations

19.

Breitbach, Caroline J., Theresa Falls, Usaf E. Aladl, et al.. (2011). Targeting Tumor Vasculature With an Oncolytic Virus. Molecular Therapy. 19(5). 886–894. 161 indexed citations

20.

Evgin, Laura, Markus Vähä‐Koskela, Julia L. Rintoul, et al.. (2010). Potent Oncolytic Activity of Raccoonpox Virus in the Absence of Natural Pathogenicity. Molecular Therapy. 18(5). 896–902. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact